Request Deal Involvement

Novo Holdings and HBM Partners led a $110m Series C round in Numab Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

MacDougall

pr advisors

MacDougall

or

Principals

NUMAB THERAPEUTICS

target

NUMAB THERAPEUTICS

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

HBM PARTNERS

bidder

HBM PARTNERS

FORBION CAPITAL PARTNERS

bidder

FORBION CAPITAL PARTNERS

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

BVF PARTNERS

bidder

BVF PARTNERS

RTW INVESTMENTS

bidder

RTW INVESTMENTS

BLACKROCK

bidder

BLACKROCK

OCTAGON CAPITAL

bidder

OCTAGON CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novo Holdings and HBM Partners led a $110m Series C round in Numab Therapeutics.